Long noncoding RNAs could be potential key players in the pathophysiology of Sjögren's syndrome

International Journal of Rheumatic Diseases

Volumn 18, Issue 8, 2015, Pages 898-905

  Sandhya, Pulukool ^a   Joshi, Kandarp ^b,c   Scaria, Vinod ^c,d  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b Open Source Drug Discovery Unit   (India)

^c ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

^d CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Autoimmunity; Expression; Interactome; LncRNA; Regulatory network; Sj gren's syndrome

Indexed keywords

CHEMOKINE; CYTOKINE; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 1BETA; LONG UNTRANSLATED RNA; TUMOR NECROSIS FACTOR ALPHA; GENETIC MARKER;

ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; HELPER CELL; HUMAN; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA SEQUENCE; SALIVARY GLAND; SJOEGREN SYNDROME; TISSUE MICROARRAY; BIOLOGY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETIC DATABASE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; RISK FACTOR; SJOGREN'S SYNDROME;

COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RISK FACTORS; RNA, LONG NONCODING; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84954379308     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12752     Document Type: Article

References (66)

1. Metzker ML (2010) Sequencing technologies - the next generation. Nat Rev Genet 11, 31-46.
2. Roberts A, Pachter L (2011) RNA-Seq and find: entering the RNA deep field. Genome Med 3, 74.
3. Harrow J, Frankish A, Gonzalez JM et al. (2012) GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22, 1760-74.
4. Bhartiya D, Kapoor S, Jalali S et al. (2012) Conceptual approaches for lncRNA drug discovery and future strategies. Expert Opin Drug Discov 7, 503-13.
5. Yan B, Wang Z-H, Liu J-Y, Tao Z-F, Li X-M, Qin J (2014) Long noncoding RNAs: versatile players in biologcial processes and human disorders. Epigenomics 6, 375-9.
6. Scaria V (2014) Joining the long shots: emerging evidence on the role of long noncoding RNAs in rheumatoid arthritis. Int J Rheum Dis 17, 831-3.
7. Mavragani CP, Moutsopoulos HM (2014) Sjögren's syndrome. Annu Rev Pathol 9, 273-85.
8. Lucchesi D, Pitzalis C, Bombardieri M (2014) EBV and other viruses as triggers of tertiary lymphoid structures in primary Sjögren's syndrome. Expert Rev Clin Immunol 10, 445-55.
9. Konttinen YT, Fuellen G, Bing Y et al. (2012) Sex steroids in Sjögren's syndrome. J Autoimmun 39, 49-56.
10. Lessard CJ, Li H, Adrianto I et al. (2013) Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet 45, 1284-92.
11. Li Y, Zhang K, Chen H et al. (2013) A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23. Nat Genet 45, 1361-5.
12. Burbelo PD, Ambatipudi K, Alevizos I (2014) Genome-wide association studies in Sjögren's syndrome: what do the genes tell us about disease pathogenesis? Autoimmun Rev 13, 756-61.
13. Gallo A, Tandon M, Illei G, Alevizos I (2014) Discovery and validation of novel microRNAs in Sjögren's syndrome salivary glands. Clin Exp Rheumatol 32, 761-2.
14. Lu Q (2013) The critical importance of epigenetics in autoimmunity. J Autoimmun 41, 1-5.
15. Michelhaugh SK, Lipovich L, Blythe J, Jia H, Kapatos G, Bannon MJ (2011) Mining Affymetrix microarray data for long non-coding RNAs: altered expression in the nucleus accumbens of heroin abusers. J Neurochem 116, 459-66.
16. Gao W, Chan JY-W, Wong T-S (2014) Differential expression of long noncoding RNA in primary and recurrent nasopharyngeal carcinoma. Biomed Res Int 2014, e404567.
17. Horvath S, Nazmul-Hossain ANM, Pollard RPE et al. (2012) Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model. Arthritis Res Ther 14, R238.
18. Greenwell-Wild T, Moutsopoulos NM, Gliozzi M et al. (2011) Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity. Arthritis Rheum 63, 3103-15.
19. Rapicavoli NA, Poth EM, Blackshaw S (2010) The long noncoding RNA RNCR2 directs mouse retinal cell specification. BMC Dev Biol 10, 49.
20. Ishii N, Ozaki K, Sato H et al. (2006) Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet 51, 1087-99.
21. Barry G, Briggs JA, Vanichkina DP et al. (2014) The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Mol Psychiatry 19, 486-94.
22. Aprea J, Prenninger S, Dori M et al. (2013) Transcriptome sequencing during mouse brain development identifies long non-coding RNAs functionally involved in neurogenic commitment. EMBO J 32, 3145-60.
23. Ishizuka A, Hasegawa Y, Ishida K, Yanaka K, Nakagawa S (2014) Formation of nuclear bodies by the lncRNA Gomafu-associating proteins Celf3 and SF1. Genes Cells 19, 704-21.
24. Van Dam S, Craig T, de Magalhães JP (2015) GeneFriends: a human RNA-seq-based gene and transcript co-expression database. Nucleic Acids Res 43, D1124-32.
25. Jalali S, Kapoor S, Sivadas A, Bhartiya D, Scaria V (2015) Computational approaches towards understanding human long non-coding RNA biology. Bioinformatics 31, 2241-51.
26. Li H, Ice JA, Lessard CJ, Sivils KL (2013) Interferons in Sjögren's syndrome: genes, mechanisms, and effects. Front Immunol 4, 290.
27. Kambara H, Niazi F, Kostadinova L et al. (2014) Negative regulation of the interferon response by an interferon-induced long non-coding RNA. Nucleic Acids Res 42, 10668-80.
28. Carpenter S, Aiello D, Atianand MK et al. (2013) A long noncoding RNA mediates both activation and repression of immune response genes. Science 341, 789-92.
29. Miyagawa R, Tano K, Mizuno R et al. (2012) Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles. RNA 18, 738-51.
30. Vigneau S, Rohrlich P-S, Brahic M, Bureau J-F (2003) Tmevpg1, a candidate gene for the control of Theiler's virus persistence, could be implicated in the regulation of gamma interferon. J Virol 77, 5632-8.
31. Collier SP, Collins PL, Williams CL, Boothby MR, Aune TM (2012) Cutting edge: influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J Immunol 189, 2084-8.
32. + T cells. Genomics 39, 171-84.
33. Heward JA, Lindsay MA (2014) Long non-coding RNAs in the regulation of the immune response. Trends Immunol 35, 408-19.
34. Petrek M, Cermáková Z, Hutyrová B et al. (2002) CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 20, 701-3.
35. Hu G, Tang Q, Sharma S et al. (2013) Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation. Nat Immunol 14, 1190-8.
36. Korman BD, Alba MI, Le JM et al. (2008) Variant form of STAT4 is associated with primary Sjögren's syndrome. Genes Immun 9, 267-70.
37. Nordmark G, Kristjansdottir G, Theander E et al. (2009) Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes Immun 10, 68-76.
38. Congrains A, Kamide K, Ohishi M, Rakugi H (2013) ANRIL: molecular mechanisms and implications in human health. Int J Mol Sci 14, 1278-92.
39. Hulkkonen J, Pertovaara M, Antonen J, Lahdenpohja N, Pasternack A, Hurme M (2001) Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Arthritis Rheum 44, 176-9.
40. Perrier S, Coussediere C, Dubost JJ, Albuisson E, Sauvezie B (1998) IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 87, 309-13.
41. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M (2001) Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 40, 656-61.
42. Gottenberg J-E, Busson M, Loiseau P et al. (2004) Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome. Arthritis Rheum 50, 570-80.
43. Shi L, Song L, Fitzgerald M, Maurer K, Bagashev A, Sullivan KE (2014) Noncoding RNAs and LRRFIP1 regulate TNF expression. J Immunol 192, 3057-67.
44. Li Z, Chao T-C, Chang K-Y et al. (2014) The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci USA 111, 1002-7.
45. Rapicavoli NA, Qu K, Zhang J, Mikhail M, Laberge R-M, Chang HY (2013) A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife 2, e00762.
46. Yuan J, Yang F, Wang F et al. (2014) A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25, 666-81.
47. Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R (2000) Fas and Fas ligand gene polymorphisms in primary Sjögren's syndrome. J Rheumatol 27, 2397-405.
48. Sehgal L, Mathur R, Braun FK et al. (2014) FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. Leukemia 28, 2376-87.
49. Kumagai S, Kanagawa S, Morinobu A et al. (1997) Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjögren's syndrome. Arthritis Rheum 40, 1685-92.
50. Nordmark G, Kristjansdottir G, Theander E et al. (2011) Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes Immun 12, 100-9.
51. Ou T-T, Lin C-H, Lin Y-C et al. (2008) IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome. J Clin Immunol 28, 440-4.
52. Chen Z, Jia S, Li D et al. (2013) Silencing of long noncoding RNA AK139328 attenuates ischemia/reperfusion injury in mouse livers. PLoS ONE 8, e80817.
53. Christensen NJ, Habekost G, Bratholm P (2008) A RNA transcript (Heg) in mononuclear cells is negatively correlated with CD14 mRNA and TSH receptor autoantibodies. Clin Exp Immunol 154, 209-15.
54. Kolkowski EC, Reth P, Pelusa F et al. (1999) Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome. J Autoimmun 13, 155-62.
55. Moriyama M, Hayashida J-N, Toyoshima T et al. (2012) Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndrome. Clin Exp Immunol 169, 17-26.
56. Gomez JA, Wapinski OL, Yang YW et al. (2013) The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus. Cell 152, 743-54.
57. Collier SP, Henderson MA, Tossberg JT, Aune TM (2014) Regulation of the Th1 genomic locus from Ifng through Tmevpg1 by T-bet. J Immunol 193, 3959-65.
58. Pasmant E, Sabbagh A, Vidaud M, Bièche I (2011) ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 25, 444-8.
59. Schaefer AS, Richter GM, Groessner-Schreiber B et al. (2009) Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genet 5, e1000378.
60. König J, Zarnack K, Luscombe NM, Ule J (2011) Protein-RNA interactions: new genomic technologies and perspectives. Nat Rev Genet 13, 77-83.
61. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY (2011) Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 44, 667-78.
62. Huarte M, Rinn JL (2010) Large non-coding RNAs: missing links in cancer? Hum Mol Genet 19, R152-61.
63. Kogo R, Shimamura T, Mimori K et al. (2011) Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 71, 6320-6.
64. Lai M, Yang Z, Zhou L et al. (2012) Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 29, 1810-6.
65. Lebenthal I, Unger R (2010) Computational evidence for functionality of noncoding mouse transcripts. Genomics 96, 10-6.
66. Haque S, Kaushik K, Leonard VE et al. (2014) Short stories on zebrafish long noncoding RNAs. Zebrafish 11, 499-508.